1. Home
  2. INMB vs EKSO Comparison

INMB vs EKSO Comparison

Compare INMB & EKSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo INmune Bio Inc.

INMB

INmune Bio Inc.

HOLD

Current Price

$1.21

Market Cap

37.2M

Sector

Health Care

ML Signal

HOLD

Logo Ekso Bionics Holdings Inc.

EKSO

Ekso Bionics Holdings Inc.

HOLD

Current Price

$11.80

Market Cap

37.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INMB
EKSO
Founded
2015
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
37.2M
37.9M
IPO Year
2018
2012

Fundamental Metrics

Financial Performance
Metric
INMB
EKSO
Price
$1.21
$11.80
Analyst Decision
Buy
Buy
Analyst Count
5
2
Target Price
$5.40
$9.50
AVG Volume (30 Days)
471.5K
88.9K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
11.85
41.76
EPS
N/A
N/A
Revenue
$50,000.00
N/A
Revenue This Year
N/A
$81.23
Revenue Next Year
N/A
$7.29
P/E Ratio
N/A
N/A
Revenue Growth
257.14
N/A
52 Week Low
$1.09
$2.88
52 Week High
$11.64
$13.50

Technical Indicators

Market Signals
Indicator
INMB
EKSO
Relative Strength Index (RSI) 37.18 60.17
Support Level $1.15 $8.30
Resistance Level $1.52 $12.39
Average True Range (ATR) 0.08 0.86
MACD -0.03 0.15
Stochastic Oscillator 5.79 79.44

Price Performance

Historical Comparison
INMB
EKSO

About INMB INmune Bio Inc.

INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.

About EKSO Ekso Bionics Holdings Inc.

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are Enterprise Health and Personal Health. All of the company's operations are held in the United States. The regions the company operates in are the Americas, EMEA, and APAC.

Share on Social Networks: